Literature DB >> 15337654

Racial disparity in the use of ECT for affective disorders.

William R Breakey1, Gary J Dunn.   

Abstract

OBJECTIVE: Published reports indicate that African Americans are underrepresented among patients treated with ECT. The reason for this disparity in practice has not been determined. This study addressed this question by using existing data on a large series of patients treated with ECT at a single academic medical center.
METHOD: The hospital's administrative databases were used to select Caucasian and African American patients with a diagnosis of major affective disorder treated over the period from November 1993 to March 2002. Independent variables were age, sex, treatment unit, readmission within 30 days, type of insurance, and geographic zone of residence. The dependent variable was likelihood of being treated with ECT, computed for each race group.
RESULTS: Caucasians were more likely than African Americans to be treated with ECT (odds ratio=4.71; 95% confidence interval [CI]=3.77-5.90). None of the variables examined provided an explanation for this disparity. When all of the variables were controlled simultaneously, the likelihood of being treated with ECT remained significantly higher for Caucasians than for African Americans (odds ratio=2.48; 95% CI=1.89-3.25).
CONCLUSIONS: The racial disparity in the use of ECT cannot be explained on the basis of the variables studied. It is not an artifact of the age of the patient population, nor can it be explained on the basis of insurance coverage, the social class of the patients, or their illnesses' being more treatment resistant. The authors propose several other hypotheses, including explanations relating to clinical presentation, differential response to other treatments, differences in patients' willingness to consent, and physicians' behavior, that could be explored by using other methods.

Entities:  

Keywords:  Empirical Approach; Mental Health Therapies

Mesh:

Year:  2004        PMID: 15337654     DOI: 10.1176/appi.ajp.161.9.1635

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  9 in total

1.  Racial differences in the availability and use of electroconvulsive therapy for recurrent major depression.

Authors:  Brady G Case; David N Bertollo; Eugene M Laska; Carole E Siegel; Joseph A Wanderling; Mark Olfson
Journal:  J Affect Disord       Date:  2011-12-12       Impact factor: 4.839

2.  Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).

Authors:  Charles H Kellner; Rebecca G Knapp; Georgios Petrides; Teresa A Rummans; Mustafa M Husain; Keith Rasmussen; Martina Mueller; Hilary J Bernstein; Kevin O'Connor; Glenn Smith; Melanie Biggs; Samuel H Bailine; Chitra Malur; Eunsil Yim; Shawn McClintock; Shirlene Sampson; Max Fink
Journal:  Arch Gen Psychiatry       Date:  2006-12

3.  Association of Electroconvulsive Therapy With Psychiatric Readmissions in US Hospitals.

Authors:  Eric P Slade; Danielle R Jahn; William T Regenold; Brady G Case
Journal:  JAMA Psychiatry       Date:  2017-08-01       Impact factor: 21.596

4.  Electroconvulsive therapy for major depression within the Veterans Health Administration.

Authors:  Paul N Pfeiffer; Marcia Valenstein; Katherine J Hoggatt; Dara Ganoczy; Dan Maixner; Erin M Miller; Kara Zivin
Journal:  J Affect Disord       Date:  2010-10-08       Impact factor: 4.839

5.  No evidence for restrictive care practices in Măori admitted to a New Zealand psychiatric inpatient unit: do specialist cultural teams have a role?

Authors:  Shailesh Kumar; Bradley Ng; Alexander Simpson; Jesse Fischer; Elizabeth Robinson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-05       Impact factor: 4.328

6.  Outcome of electroconvulsive therapy by race in the Consortium for Research on Electroconvulsive Therapy multisite study.

Authors:  Mark D Williams; Teresa Rummans; Shirlene Sampson; Rebecca Knapp; Martina Mueller; Mustafa M Husain; Max Fink; Keith Rasmussen; Kevin O'Connor; Glenn Smith; George Petrides; Charles H Kellner
Journal:  J ECT       Date:  2008-06       Impact factor: 3.635

7.  The efficacy of acute electroconvulsive therapy in atypical depression.

Authors:  Mustafa M Husain; Shawn M McClintock; A John Rush; Rebecca G Knapp; Max Fink; Teresa A Rummans; Keith Rasmussen; Cynthia Claassen; Georgios Petrides; Melanie M Biggs; Martina Mueller; Shirlene Sampson; Samuel H Bailine; Sarah H Lisanby; Charles H Kellner
Journal:  J Clin Psychiatry       Date:  2008-03       Impact factor: 4.384

8.  Demographics of Patients Receiving Electroconvulsive Therapy Based on State-Mandated Reporting Data.

Authors:  James Luccarelli; Michael E Henry; Thomas H McCoy
Journal:  J ECT       Date:  2020-12       Impact factor: 3.692

9.  Electroconvulsive Therapy in Veterans Health Administration Hospitals: Prevalence, Patterns of Use, and Patient Characteristics.

Authors:  Talya Peltzman; Daniel J Gottlieb; Brian Shiner; Natalie Riblet; Bradley V Watts
Journal:  J ECT       Date:  2020-06       Impact factor: 3.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.